Drug Shortage Report for TOBI PODHALER
| Report ID | 236492 |
| Drug Identification Number | 02365154 |
| Brand name | TOBI PODHALER |
| Common or Proper name | TOBRAMYCIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 28MG |
| Dosage form(s) | CAPSULE |
| Route of administration | INHALATION INHALATION |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 4(7x8) |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-11-01 |
| Actual start date | 2024-10-25 |
| Estimated end date | 2025-01-20 |
| Actual end date | 2025-01-20 |
| Shortage status | Resolved |
| Updated date | 2025-01-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.